Blockade of CXCR2 receptors in TAMs with AZD5069 disrupts the CXCL2-CXCR2 pathway and triggers the reprogramming of TAMs toward a pro-inflammatory state, resulting in PCa cell senescence and the inhibition of tumor progression [53]. The gene discussed is CXCL2; the disease is neoplasm.